Results 51 to 60 of about 28,950 (250)

Particle radiotherapy for breast cancer

open access: yesFrontiers in Oncology, 2023
Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer.
Hanguang Ruan   +8 more
doaj   +1 more source

His+ reversions Caused in Salmonella typhimurium by different types of ionizing radiation [PDF]

open access: yes, 1988
The yield of his+ reversions in the Ames Salmonella tester strain TA2638 has been determined for 60Co γ rays, 140 kV X rays, 5.4 keV characteristic X rays, 2.2 MeV protons, 3.1 MeV α particles, and 18 MeV/U Fe ions.
Fitzek, M.   +3 more
core   +1 more source

Carbon-ion radiotherapy for inoperable endometrial carcinoma [PDF]

open access: yesJournal of Radiation Research, 2018
This is a pooled analysis to evaluate the toxicity and efficacy of carbon-ion radiotherapy (C-ion RT) for inoperable endometrial carcinoma. Eligible patients had previously untreated Stage I-III endometrial carcinoma without para-aortic lymph node metastasis.
Irie, Daisuke   +11 more
openaire   +2 more sources

Detailed analysis of the cell-inactivation mechanism by accelerated protons and light ions

open access: yes, 2005
Published survival data for V79 cells irradiated by monoenergetic protons, helium-3, carbon, and oxygen ions and for CHO cells irradiated by carbon ions have been analyzed using the probabilistic two-stage model of cell inactivation.
Berger M J Coursey J S Zucker M A   +21 more
core   +1 more source

Double di ffential fragmentation cross sections measurements of 95 MeV/u 12C on thin targets for hadrontherapy [PDF]

open access: yes, 2013
During therapeutic treatment with heavy ions like carbon, the beam undergoes nuclear fragmentation and secondary light charged particles, in particular protons and alpha particles, are produced.
Braunn, B.   +14 more
core   +5 more sources

Carbon Ion Radiotherapy for Unresectable Sacral Chordomas [PDF]

open access: yesClinical Cancer Research, 2004
Abstract Purpose: The purpose is to evaluate the efficacy and toxicity of carbon ion radiotherapy for unresectable sacral chordomas. Experimental Design: We performed a retrospective analysis of 30 patients with unresectable sacral chordomas treated with carbon ion radiotherapy at the Heavy Ion Medical Accelerator in Chiba,
Reiko, Imai   +10 more
openaire   +2 more sources

Types and Incidence of Moderate and Severe Toxic Effects of Carbon Ion Radiotherapy for Head and Neck Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2023
Head and neck tumors often have complex anatomical structures and are adjacent to important organs. Radiation injury caused by conventional radiotherapy technology is the main dose-limiting factor.
YANG Pengcheng   +3 more
doaj   +1 more source

Chordoma. Clinical characteristics, management and prognosis of a case series of 25 patients [PDF]

open access: yes, 2010
Background: Adequate surgery still remains the only curative treatment of chordoma. Interesting clinical data on advanced disease with molecularly targeted therapies were reported.Methods: We described the clinical outcome of a series of chordoma ...
Virginia Ferraresi   +45 more
core   +1 more source

Radiation-induced organizing pneumonia caused by carbon-ion radiotherapy for lung cancer

open access: yesRadiology Case Reports
Radiation-induced organizing pneumonia is a rare complication of radiation therapy for thoracic cancer. Carbon-ion radiotherapy, an emerging treatment modality for early-stage lung cancer treatment, can also cause lung injuries.
Yu Shionoya   +7 more
doaj   +1 more source

Carbon Ion Beam Radiotherapy for Sinonasal Malignant Tumors Invading Skull Base

open access: yesCase Reports in Otolaryngology, 2014
Objective. To evaluate the treatment outcome and prognostic factors in patients with sinonasal malignant tumors invading skull base. Study Design and Setting. A retrospective clinical study at the Yamagata University School of Medicine.
Nobuo Ohta   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy